Total Visits

Views
Initial results of a clinical trial evaluating a full-length pegylated recombinant factor viii with extended half-life for the perioperative control of hemostasis in hemophilia A11

Select a period of time:

Views

Views
November 20230
December 20230
January 20241
February 20240
March 20241
April 20240
May 20243
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Chicago2
Boardman1